Cencora, Inc. COR
306.92
(2.95)
(0.95%)
as of 25 Sep
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cencora, Inc. (COR) Net income
Cencora, Inc.'s net income for fiscal 2025 was $1.6B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $2.6B. Over the past ten years it has ranged from −$3.4B (fiscal 2020) to $1.7B (fiscal 2023); the current reading is higher than 73% of that period. Cencora, Inc. ranks 2nd of 11 Medical Distribution companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.6B | 3.20% |
| FY2024 | $1.5B | (12.31%) |
| FY2023 | $1.7B | 3.96% |
| FY2022 | $1.7B | 7.89% |
| FY2021 | $1.5B | — |
| FY2020 | −$3.4B | — |
| FY2019 | $854.1M | (47.14%) |
| FY2018 | $1.6B | 343.34% |
| FY2017 | $364.5M | (74.47%) |
| FY2016 | $1.4B | — |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $776.7M | (52.34%) |
| Mar 2026 | $1.6B | 187.84% |
| Dec 2025 | $566.1M | — |
| Sep 2025 | −$333.1M | — |
| 42 more quarters | Free account |
Against its own ten years
Low −$3.4B
High $1.7B
Ten-year median
$1.5B
Current reading's percentile
73
Net income against peers
| Company | Net income |
|---|---|
| MCK McKesson Corporation compare | $5.3B |
| COR Cencora, Inc. | $2.6B |
| CAH Cardinal Health, Inc. compare | $1.7B |
| HSIC Henry Schein, Inc. compare | $426.0M |
| YI 111, Inc. Sponsored ADR compare | −$3.2M |
| AHG Akso Health Group Sponsored ADR compare | −$19.2M |
| COSM Cosmos Health Inc. compare | −$24.4M |
| FOCL FocalTherics compare | −$39.0M |
| ACH Accendra Health, Inc. compare | −$302.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on COR
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement